Respiratory drugs and macrolides prevent asthma exacerbations: A real-world investigation

Respiratory Medicine

Volumn 119, Issue , 2016, Pages 7-12

  Arfè, Andrea ^a   Blasi, Francesco ^b   Merlino, Luca ^c   Corrao, Giovanni ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Operative Unit of Territorial Health Services   (Italy)

Author keywords

Antibiotics; Asthma; Beta agonists; Corticosteroids; Effectiveness; Emergency visits; Exacerbations; Macrolides

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA LACTAM; CORTICOSTEROID; MACROLIDE; MUSCARINIC RECEPTOR BLOCKING AGENT; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSSOVER PROCEDURE; DISEASE EXACERBATION; DRUG EFFICACY; EMERGENCY WARD; FEMALE; HEALTH CARE UTILIZATION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC ERROR; COMPARATIVE STUDY; EPIDEMIOLOGY; HOSPITAL EMERGENCY SERVICE; INHALATIONAL DRUG ADMINISTRATION; OUTCOME ASSESSMENT; YOUNG ADULT;

ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-2 RECEPTOR AGONISTS; ADULT; ANTI-BACTERIAL AGENTS; ASTHMA; CHILD; CROSS-OVER STUDIES; DISEASE PROGRESSION; EMERGENCY SERVICE, HOSPITAL; HUMANS; ITALY; MACROLIDES; OUTCOME ASSESSMENT (HEALTH CARE); YOUNG ADULT;

EID: 84983084790     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2016.05.004     Document Type: Article

References (34)

1. [1] Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention 2015. Available from: www.ginasthma.org.
2. [2] Bahadori, K., Doyle-Waters, M.M., Marra, C., Lynd, L., Alasaly, A., Swinton, J., et al. Economic burden of asthma: a systematic review. BMC Pulm. Med., 9, 2009, e24.
3. [3] de Marco, R., Cappa, V., Accordini, S., Rava, M., Antonicalli, L., Bortolami, O., et al. GEIRD Study Group. Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010. Eur. Respir. J. 39 (2012), 883–892.
4. [4] Accordini, S., Corsico, A., Cerveri, I., Gislason, D., Gulsvik, A., Janson, C., et al. Therapy and health economics working group of the European Community Respiratory Health Survey II. The socio-economic burden of asthma is substantial in Europe. Allergy 63 (2008), 116–124.
5. [5] Reddel, H., Ware, S., Marks, G., Salome, C., Jenkins, C., Woolcock, A., Differences between asthma exacerbations and poor asthma control [erratum in Lancet 1999; 353:758]. Lancet 353 (1999), 364–369.
6. [6] Pauwels, R.A., Pedersen, S., Busse, W.W., Tan, W.C., Chen, Y.Z., Ohlsson, S.V., Ullman, A., Lamm, C.J., O'Byrne, P.M., START Investigators Group. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 361 (2003), 1071–1076.
7. [7] Long, W., Li, L., Huang, G., Zhang, X., Zhang, Y., Tang, J., Zhang, Y., Lu, G., Procalcitonin guidance for reduction of antibiotic use in patients hospitalized with severe acute exacerbations of asthma: a randomized controlled study with 12-month follow-up. Crit. Care, 18, 2014, 471.
8. [8] Graham, V., Lasserson, T.J., Rowe, B.H., Antibiotics for acute asthma. Cochrane Database Syst. Rev.(3), 2001 CD002741.
9. [9] O'Byrne, P.M., Barnes, P.J., Rodriguez-Roisin, R., Runnerstrom, E., Sandstrom, T., Svensson, K., Tattersfield, A., Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am. J. Respir. Crit. Care Med. 164 (2001), 1392–1397.
10. [10] Adams, N.P., Bestall, J.B., Malouf, R., Lasserson, T.J., Jones, P.W., Inhaled beclomethasone versus placebo for chronic asthma. Cochrane Database Syst. Rev.(1), 2005 CD002738.
11. [11] Black, P.N., Antibiotics for the treatment of asthma. Curr. Opin. Pharmacol. 7 (2007), 266–271.
12. [12] Piovani, D., Clavenna, A., Cartabia, M., Bonati, M., Interregional Italian Drug Utilisation Group. Antibiotic and anti-asthmatic drug prescriptions in Italy: geographic patterns and socio-economic determinants at the district level. Eur. J. Clin. Pharmacol. 70 (2014), 331–337.
13. [13] Corrao, G., Cesana, G., Merlino, L., Pharmacoepidemiological research and the linking of electronic healthcare databases available in the Italian region of Lombardy. Biomed. Stat. Clin. Epidemiol. 2 (2008), 111–125.
14. [14] Delaney, J.A., Suissa, S., The case-crossover study design in pharmacoepidemiology. Stat. Methods Med. Res. 18 (2009), 53–65.
15. [15] Hosmer, D.W., Lemeshow, S., Applied Logistic Regression. 3nd ed., 2013, John Wiley & Sons, Hoboken, New Jersey.
16. [16] Horwitz, R.I., Feinstein, A.R., The problem of ‘‘protopathic bias’’ in case-control studies. Am. J. Med. 68 (1980), 255–258.
17. [17] Tamim, H., Monfared, A.A., LeLorier, J., Application of lag-time into exposure definitions to control for protopathic bias. Pharmacoepidemiol. Drug Saf. 16 (2007), 250–258.
18. [18] Wang, S., Linkletter, C., Maclure, M., Dore, D., Mor, V., Buka, S., et al. Future cases as present controls to adjust for exposure trend bias in case-only studies. Epidemiology 22 (2011), 568–574.
19. [19] Rothwell, P.M., External validity of randomised controlled trials: “to whom do the results of this trial apply?”. Lancet 365 (2005), 82–93.
20. [20] Nallamothu, B.K., Hayward, R.A., Bates, E.R., Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies. Circulation 118 (2008), 1294–1303.
21. [21] Edmonds, M.L., Milan, S.J., Camargo, C.A. Jr., Pollack, C.V., Rowe, B.H., Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst. Rev., 12, 2012 CD002308.
22. [22] Marceau, C., Lemière, C., Berbiche, D., Perreault, S., Blais, L., Persistence, adherence, and effectiveness of combination therapy among adult patients with asthma. J. Allergy Clin. Immunol. 118 (2006), 574–581.
23. [23] Edwards, S.J., von Maltzahn, R., Naya, I.P., Harrison, T., Budesonide/formoterol for maintenance and reliever therapy of asthma: a meta analysis of randomised controlled trials. Int. J. Clin. Pract. 64 (2010), 619–627.
24. [24] Wells, K.E., Peterson, E.L., Ahmedani, B.K., Severson, R.K., Gleason-Comstock, J., Williams, L.K., The relationship between combination inhaled corticosteroid and long-acting β-agonist use and severe asthma exacerbations in a diverse population. J. Allergy Clin. Immunol. 129 (2012), 1274–1279.
25. [25] Tong, X., Guo, T., Liu, S., Peng, S., Yan, Z., Yang, X., Zhang, Y., Fan, H., Macrolide antibiotics for treatment of asthma in adults: a meta-analysis of 18 randomized controlled clinical studies. Pulm. Pharmacol. Ther. 31 (2015), 99–108.
26. [26] Richeldi, L., Ferrara, G., Fabbri, L.M., Lasserson, T.J., Gibson, P.G., Macrolides for chronic asthma. Cochrane Database Syst. Rev.(4), 2005 CD002997.
27. [27] Brusselle, G.G., Joos, G., Is there a role for macrolides in severe asthma?. Curr. Opin. Pulm. Med. 20 (2014), 95–102.
28. [28] Wenzel, R.P., Wong, M.T., Managing antibiotic use – impact of infection control. Clin. Infect. Dis. 28 (1999), 1126–1127.
29. [29] Johnston, S.L., Blasi, F., Black, P.N., Martin, R.J., Farrell, D.J., Nieman, R.B., TELICAST Investigators. The effect of telithromycin in acute exacerbations of asthma. N. Engl. J. Med. 354:15 (2006 Apr 13), 1589–1600.
30. [30] Rodrigo, G.J., Castro-Rodríguez, J.A., What is the role of tiotropium in asthma? A systematic review with meta-analysis. Chest 147 (2015), 388–396.
31. [31] Zimmermann, G.S., Neurohr, C., Villena-Hermoza, H., Hatz, R., Behr, J., Anti-inflammatory effects of antibacterials on human bronchial epithelial cells. Respir. Res., 10, 2009, 89.
32. [32] Shalit, I., Horev-Azaria, L., Fabian, I., Blau, H., Kariv, N., Shechtman, I., Alterz, H., Immunomodulatory Kletter, Y., Protective effects of moxifloxacin against Candida albicans-induced bronchopneumonia in mice injected with cyclophosphamide. Antimicrob. Agents Chemother. 46 (2002), 2442–2449.
33. [33] Van Dole, K.B., Swern, A.S., Newcomb, K., Nelsen, L., Seasonal patterns in health care use and pharmaceutical claims for asthma prescriptions for preschool- and school-aged children. Ann. Allergy Asthma Immunol. 102 (2009), 198–204.
34. [34] Corrao, G., Mancia, G., Generating evidence from computerized healthcare utilization databases. Hypertension 65 (2015), 490–498.